Skip to main navigation Skip to search Skip to main content

Navigating the Therapeutic Pathway and Optimal First-Line Systemic Therapy for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors

Research output: Contribution to journal › Review article › peer-review

5 Citations (Scopus)

Search results